Craig Witz
Reproductive Endocrinology · Houston, TXNPI 1710993621
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Ferring Pharmaceuticals Inc. accounts for 62.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $13,036 and has fallen 98.2% since, to $230 in 2024. Among reproductive endocrinology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $296.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$20K
- Ferring Pharmaceuticals (asia) Co. Ltd.$6K
- Ferring International Center SA$6K
- EMD Serono, Inc.$397
- Coopersurgical, Inc.$226
- AbbVie$118
- plus $191 from 5 others
Across 116 payments — averaging $17,648 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring International Pharmascience Center US$2M
- Siemens Medical Solutions USA, Inc.$8K
- IBSA Institut Biochimique SA$3K
What the payments were for
- Consulting fees$11,54036%
- Speaking & faculty fees$15,23947%
- Travel & lodging$2,9109%
- Food & beverage$2,6518%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 73 | $20,209 |
| Ferring Pharmaceuticals (asia) Co. Ltd. | 1 | $5,600 |
| Ferring International Center SA | 1 | $5,600 |
| EMD Serono, Inc. | 18 | $397 |
| Coopersurgical, Inc. | 3 | $226 |
| AbbVie | 1 | $118 |
| Merck | 4 | $67 |
| Organon | 5 | $48 |
| Boston Scientific | 1 | $32 |
| Medtronic | 1 | $29 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MENOPUR$23,045
- ENDOMETRIN$1,190
- INVOCELL$125
- Orilissa$118
- STRIPPER$114
How this compares
$32,340 in reported general payments places this provider in the 90th percentile of 142 reproductive endocrinology providers in Texas.
Other reproductive endocrinology in Houston
- Randall DunnHouston$234K
- Jason YehHouston$31K
- Katherine McKnightHouston$13K
- James NodlerHouston$11K
- Ghassan HaddadHouston$7K
- Nischelle KalakotaHouston$3K
- Guillermo RoweHouston$3K
- George GrunertHouston$3K
- Toral ParikhHouston$2K
- Timothy DunnHouston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.